Comparison of 4- and 4 plus-courses S-1 administration as adjuvant chemotherapy for pancreatic ductal adenocarcinoma

PURPOSE: The study aimed to investigate the potential benefit of more than 4 courses of S1 adjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma (PDAC) after surgery. METHOD: Data were retrospectively collected from consecutive patients who underwent S-1 adjuvant chemotherapy foll...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Bo, Shen, Shuo, You, Siting, Zhang, Guoxiao, Gao, Suizhi, Shi, Xiaohan, Wang, Huan, Yin, Xiaoyi, Xu, Xiongfei, Guo, Shiwei, Jin, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152347/
https://www.ncbi.nlm.nih.gov/pubmed/34034684
http://dx.doi.org/10.1186/s12885-021-08380-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152347/
https://www.ncbi.nlm.nih.gov/pubmed/34034684
http://dx.doi.org/10.1186/s12885-021-08380-9

Ejemplares similares